Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2010

Open Access 01-12-2010 | Original investigation

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population

Authors: Farzad Hadaegh, Nooshin Fahimfar, Davood Khalili, Farhad Sheikholeslami, Fereidoun Azizi

Published in: Cardiovascular Diabetology | Issue 1/2010

Login to get access

Abstract

Background

To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East population with high prevalence of diabetes mellitus (DM).

Methods

A population based cohort study of 2267 men and 2931 women, aged ≥ 30 years. Prior CHD was defined as self-reported or ECG positive CHD at baseline, KDM as subjects using any kind of glucose-lowering medications and NDM according to fasting plasma glucose and 2-h postchallenge glycemia.
Participants were categorized to six groups according to the presence of known or newly diagnosed DM and CHD at baseline (DM-/CHD-, DM-/CHD+, NDM+/CHD-, NDM+/CHD+, KDM+/CHD-, KDM+/CHD+) and Cox regression analysis were used to estimate the hazard ratio (HR) of CHD events for these DM/CHD groups, given DM-/CHD-as the reference.

Results

During 7.6-year follow up, 358 CHD events occurred. After controlling traditional risk factors, HRs of CHD events for DM-/CHD+ group were 2.1 (95% CI: 1.4-3.1) and 5.2 (3.2-8.3) in men and women respectively. Corresponding HRs for NDM+/CHD-were 1.7 (1.1-2.7) and 3.1 (1.8-5.6) and for KDM+/CHD-were 1.7 (0.9-3.3) and 6.2 (3.6-10.6) in men and women respectively. The HRs for NDM+/CHD+ and KDM+/CHD+ groups (i.e. participants with history of both diabetes and CHD) were 6.4 (3.2-12.9) and 8.0 (4.3-14.8) in women and 3.2 (1.9-5.6) and 4.2 (2.2-7.8) in men, respectively.
The hazard of CHD events did not differ between KDM+/CHD-and DM-/CHD+ in both genders using paired homogeneity test, however the HR for NDM+/CHD-was marginally lower than the HR for DM-/CHD+ in women (p = 0.085).

Conclusions

KDM patients in both genders and NDM especially in men exhibited a CHD risk comparable to nondiabetics with a prior CHD, furthermore diabetic subjects with prior CHD had the worst prognosis, by far more harmful in women than men; reinforcing the urgent need for intensive care and prophylactic treatment for cardiovascular diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB: Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care. 2006, 29: 391-397. 10.2337/diacare.29.02.06.dc05-1299.CrossRefPubMed Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB: Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care. 2006, 29: 391-397. 10.2337/diacare.29.02.06.dc05-1299.CrossRefPubMed
2.
go back to reference Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005, 28: 2901-2907. 10.2337/diacare.28.12.2901.CrossRefPubMed Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005, 28: 2901-2907. 10.2337/diacare.28.12.2901.CrossRefPubMed
3.
go back to reference Whiteley L, Padmanabhan S, Hole D, Isles C: Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care. 2005, 28: 1588-1593. 10.2337/diacare.28.7.1588.CrossRefPubMed Whiteley L, Padmanabhan S, Hole D, Isles C: Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care. 2005, 28: 1588-1593. 10.2337/diacare.28.7.1588.CrossRefPubMed
4.
go back to reference Gruppetta M, Calleja N, Fava S: Long-term survival after acute myocardial infarction and relation to type 2 diabetes and other risk factors. Clin Cardiol. 33: 424-429. 10.1002/clc.20776. Gruppetta M, Calleja N, Fava S: Long-term survival after acute myocardial infarction and relation to type 2 diabetes and other risk factors. Clin Cardiol. 33: 424-429. 10.1002/clc.20776.
5.
go back to reference Standards of medical care in diabetes--2009. Diabetes Care. 2009, 32 (Suppl 1): S13-61. Standards of medical care in diabetes--2009. Diabetes Care. 2009, 32 (Suppl 1): S13-61.
6.
go back to reference Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB: The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002, 40: 954-960. 10.1016/S0735-1097(02)02044-2.CrossRefPubMed Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB: The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002, 40: 954-960. 10.1016/S0735-1097(02)02044-2.CrossRefPubMed
7.
go back to reference Evans JM, Wang J, Morris AD: Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002, 324: 939-942. 10.1136/bmj.324.7343.939.PubMedCentralCrossRefPubMed Evans JM, Wang J, Morris AD: Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002, 324: 939-942. 10.1136/bmj.324.7343.939.PubMedCentralCrossRefPubMed
8.
go back to reference Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J: Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2004, 164: 1438-1443. 10.1001/archinte.164.13.1438.CrossRefPubMed Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J: Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2004, 164: 1438-1443. 10.1001/archinte.164.13.1438.CrossRefPubMed
9.
go back to reference Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J. 2003, 24: 1406-1413. 10.1016/S0195-668X(03)00197-0.CrossRefPubMed Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J. 2003, 24: 1406-1413. 10.1016/S0195-668X(03)00197-0.CrossRefPubMed
10.
go back to reference Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16: 434-444. 10.2337/diacare.16.2.434.CrossRefPubMed
11.
go back to reference Nijjar AP, Wang H, Dasgupta K, Rabi DM, Quan H, Khan NA: Outcomes in a diabetic population of South Asians and whites following hospitalization for acute myocardial infarction: a retrospective cohort study. Cardiovasc Diabetol. 2010, 9: 4-10.1186/1475-2840-9-4.PubMedCentralCrossRefPubMed Nijjar AP, Wang H, Dasgupta K, Rabi DM, Quan H, Khan NA: Outcomes in a diabetic population of South Asians and whites following hospitalization for acute myocardial infarction: a retrospective cohort study. Cardiovasc Diabetol. 2010, 9: 4-10.1186/1475-2840-9-4.PubMedCentralCrossRefPubMed
12.
go back to reference Diabetes Atlas. 2006, Brussels: International Diabetes Federation Diabetes Atlas. 2006, Brussels: International Diabetes Federation
13.
go back to reference Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world--a growing challenge. N Engl J Med. 2007, 356: 213-215. 10.1056/NEJMp068177.CrossRefPubMed Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world--a growing challenge. N Engl J Med. 2007, 356: 213-215. 10.1056/NEJMp068177.CrossRefPubMed
14.
go back to reference Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F: High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health. 2008, 8: 176-10.1186/1471-2458-8-176.PubMedCentralCrossRefPubMed Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F: High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health. 2008, 8: 176-10.1186/1471-2458-8-176.PubMedCentralCrossRefPubMed
15.
go back to reference Harati H, Hadaegh F, Saadat N, Azizi F: Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009, 9: 186-10.1186/1471-2458-9-186.PubMedCentralCrossRefPubMed Harati H, Hadaegh F, Saadat N, Azizi F: Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009, 9: 186-10.1186/1471-2458-9-186.PubMedCentralCrossRefPubMed
16.
go back to reference Ghassemi H, Harrison G, Mohammad K: An accelerated nutrition transition in Iran. Public Health Nutr. 2002, 5: 149-155. 10.1079/PHN2001287.CrossRefPubMed Ghassemi H, Harrison G, Mohammad K: An accelerated nutrition transition in Iran. Public Health Nutr. 2002, 5: 149-155. 10.1079/PHN2001287.CrossRefPubMed
17.
go back to reference Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO, Ahmed NM, Nazirudeen MK, Al Sayed MF, Nour FA, Abdouni S: Associations of cardiovascular risk factors in Al Ain, United Arab Emirates. Cardiovasc Diabetol. 2009, 8: 21-10.1186/1475-2840-8-21.PubMedCentralCrossRefPubMed Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO, Ahmed NM, Nazirudeen MK, Al Sayed MF, Nour FA, Abdouni S: Associations of cardiovascular risk factors in Al Ain, United Arab Emirates. Cardiovasc Diabetol. 2009, 8: 21-10.1186/1475-2840-8-21.PubMedCentralCrossRefPubMed
18.
go back to reference Hadaegh F, Harati H, Ghanbarian A, Azizi F: Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J. 2009, 15: 157-166.PubMed Hadaegh F, Harati H, Ghanbarian A, Azizi F: Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J. 2009, 15: 157-166.PubMed
19.
go back to reference Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F: Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest. 2009, 32: 724-730.CrossRefPubMed Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F: Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest. 2009, 32: 724-730.CrossRefPubMed
20.
go back to reference Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009, 10: 5.PubMedCentralCrossRefPubMed Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009, 10: 5.PubMedCentralCrossRefPubMed
21.
go back to reference prineas RjCR, Blackburn H: The minnesota code mannual of electrocardiographic findings: standards and procedures for measurement and classification. 1982, Boston: Wright-PSG prineas RjCR, Blackburn H: The minnesota code mannual of electrocardiographic findings: standards and procedures for measurement and classification. 1982, Boston: Wright-PSG
22.
go back to reference Ford ES, Giles WH, Croft JB: Prevalence of nonfatal coronary heart disease among American adults. Am Heart J. 2000, 139: 371-377. 10.1016/S0002-8703(00)90076-0.CrossRefPubMed Ford ES, Giles WH, Croft JB: Prevalence of nonfatal coronary heart disease among American adults. Am Heart J. 2000, 139: 371-377. 10.1016/S0002-8703(00)90076-0.CrossRefPubMed
23.
go back to reference Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F: Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009, 19: 401-408. 10.1016/j.numecd.2008.09.003.CrossRefPubMed Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F: Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009, 19: 401-408. 10.1016/j.numecd.2008.09.003.CrossRefPubMed
24.
go back to reference Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.CrossRefPubMed
25.
go back to reference Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, Hansen ML, Folke F, Buch P, Madsen M: Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008, 117: 1945-1954. 10.1161/CIRCULATIONAHA.107.720847.CrossRefPubMed Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, Hansen ML, Folke F, Buch P, Madsen M: Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008, 117: 1945-1954. 10.1161/CIRCULATIONAHA.107.720847.CrossRefPubMed
26.
go back to reference Lee CD, Folsom AR, Pankow JS, Brancati FL: Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004, 109: 855-860. 10.1161/01.CIR.0000116389.61864.DE.CrossRefPubMed Lee CD, Folsom AR, Pankow JS, Brancati FL: Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004, 109: 855-860. 10.1161/01.CIR.0000116389.61864.DE.CrossRefPubMed
27.
go back to reference Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE: The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001, 161: 1717-1723. 10.1001/archinte.161.14.1717.CrossRefPubMed Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE: The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001, 161: 1717-1723. 10.1001/archinte.161.14.1717.CrossRefPubMed
28.
go back to reference Krempf M, Parhofer KG, Steg PG, Bhatt DL, Ohman EM, Rother J, Goto S, Pasquet B, Wilson PW: Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010, 105: 667-671. 10.1016/j.amjcard.2009.10.048.CrossRefPubMed Krempf M, Parhofer KG, Steg PG, Bhatt DL, Ohman EM, Rother J, Goto S, Pasquet B, Wilson PW: Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol. 2010, 105: 667-671. 10.1016/j.amjcard.2009.10.048.CrossRefPubMed
29.
go back to reference Gonzalez-Clemente JM, Palma S, Arroyo J, Vilardell C, Caixas A, Gimenez-Palop O, Delgado-Rodriguez M: [Is diabetes mellitus a coronary heart disease equivalent? Results of a meta-analysis of prospective studies]. Rev Esp Cardiol. 2007, 60: 1167-1176. 10.1157/13111789.CrossRefPubMed Gonzalez-Clemente JM, Palma S, Arroyo J, Vilardell C, Caixas A, Gimenez-Palop O, Delgado-Rodriguez M: [Is diabetes mellitus a coronary heart disease equivalent? Results of a meta-analysis of prospective studies]. Rev Esp Cardiol. 2007, 60: 1167-1176. 10.1157/13111789.CrossRefPubMed
30.
go back to reference Eberly LE, Cohen JD, Prineas R, Yang L: Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care. 2003, 26: 848-854. 10.2337/diacare.26.3.848.CrossRefPubMed Eberly LE, Cohen JD, Prineas R, Yang L: Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care. 2003, 26: 848-854. 10.2337/diacare.26.3.848.CrossRefPubMed
31.
go back to reference Carnethon MR, Biggs ML, Barzilay J, Kuller LH, Mozaffarian D, Mukamal K, Smith NL, Siscovick D: Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med. 2010, 123: 556-559. 10.1016/j.amjmed.2009.11.023. e551PubMedCentralCrossRefPubMed Carnethon MR, Biggs ML, Barzilay J, Kuller LH, Mozaffarian D, Mukamal K, Smith NL, Siscovick D: Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med. 2010, 123: 556-559. 10.1016/j.amjmed.2009.11.023. e551PubMedCentralCrossRefPubMed
32.
go back to reference Andersson C, Gislason GH, Weeke P, Hoffmann S, Hansen PR, Torp-Pedersen C, Sogaard P: Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol. 2010, 9: 3-10.1186/1475-2840-9-3.PubMedCentralCrossRefPubMed Andersson C, Gislason GH, Weeke P, Hoffmann S, Hansen PR, Torp-Pedersen C, Sogaard P: Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol. 2010, 9: 3-10.1186/1475-2840-9-3.PubMedCentralCrossRefPubMed
33.
go back to reference Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H: Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol. 2006, 5: 15-10.1186/1475-2840-5-15.PubMedCentralCrossRefPubMed Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H: Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol. 2006, 5: 15-10.1186/1475-2840-5-15.PubMedCentralCrossRefPubMed
34.
go back to reference Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007, 116: 151-157. 10.1161/CIRCULATIONAHA.106.685628.CrossRefPubMed Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007, 116: 151-157. 10.1161/CIRCULATIONAHA.106.685628.CrossRefPubMed
35.
go back to reference Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Despres JP, Bernard PM, Bogaty P: Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. Cmaj. 2009, 180: 40-47.PubMedCentralCrossRefPubMed Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Despres JP, Bernard PM, Bogaty P: Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. Cmaj. 2009, 180: 40-47.PubMedCentralCrossRefPubMed
Metadata
Title
New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
Authors
Farzad Hadaegh
Nooshin Fahimfar
Davood Khalili
Farhad Sheikholeslami
Fereidoun Azizi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2010
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-9-84

Other articles of this Issue 1/2010

Cardiovascular Diabetology 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.